Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001104659-25-122583·KPCB PANDEMIC & BIO DEFENSE FUND LLC
Schedule 13G ownership disclosure
Sagimet Biosciences Inc
Series A Common Stock, $0.0001 par value per share · CUSIP: 786700104
Event date: 2025-12-18
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- KPCB Pandemic and Bio Defense Fund, LLC
Shares: 0.00 · Class: 0.0%
- KPCB PBD Associates, LLC
Shares: 0.00 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-122583
- Form type
- SCHEDULE 13G/A
- Filer
- KPCB PANDEMIC & BIO DEFENSE FUND LLC
- CIK
- CIK 1356809
- Filed
- Dec 18, 2025
- Reporting period
- Dec 18, 2025
- Description
- Schedule 13G beneficial ownership